• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

U.S. House panel approves three bills aimed at tackling high drug prices

September 29, 2021 by David Barret Leave a Comment

September 29, 2021

By Diane Bartz

WASHINGTON (Reuters) – The U.S. House Judiciary Committee voted on Wednesday to approve three bills to stop practices drugmakers use to raise prices and fend off competition, including a bill to ban the tactic of paying generic companies to delay bringing cheaper versions of their medicines to market.

While the votes were not unanimous, they passed the committee by a big margin. A fourth measure is set to be considered on Thursday.

Committee Chairman Jerrold Nadler said the Congressional Budget Office had estimated that banning so-called pay-for-delay patent deals used to stall generic competition – the subject of one of the bills – would save Americans more than half a billion dollars over 10 years.

The measures were introduced in a rare hearing that mixed members of the House and Senate, during which lawmakers from both parties and from both chambers said they had introduced the bills aimed at ultimately lowering the cost of prescription medicines for Americans. Four identical bills were introduced in the House and Senate.

The House Judiciary Committee voted on Wednesday to enable the Federal Trade Commission to ban sham citizen petitions, in which drug companies petition the U.S. Food and Drug Administration about a generic company seeking approval for a rival drug with the goal of delaying its market entry.

Brand name drugs can fairly quickly lose more than 80% of their sales revenue once multiple generic versions reach the market.

They also approved a measure to stop product-hopping, the practice of making a minor tweak to the formula of a medication to win a new patent and therefore a longer period of exclusivity, and would also stop pay-for-delay patent deals.

The Senate Judiciary Committee approved the measures in July, all on a voice vote.

The House Judiciary committee is set to vote on Thursday on the last measure, which would make it easier to bring to market biosimilars, cheaper versions of expensive biotech drugs that cannot be exactly duplicated, unlike pills.

The measures must next be taken up by the full House and Senate.

(Reporting by Diane Bartz; Editing by Bill Berkrot)

Source Link U.S. House panel approves three bills aimed at tackling high drug prices

David Barret
David Barret

Related posts:

  1. Myanmar’s Suu Kyi back in court after absence, still ‘somewhat dizzy’ -lawyer
  2. Vladimir Putin is to self-isolate after COVID-19 detected in entourage – Kremlin
  3. Commission chief tells Albania: your future is in the EU
  4. Barty returns to Australia to see family, no decision on rest of season

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • DNA From Greenland Sled Dogs – Maybe The World’s Oldest Breed – Reveals 1,000 Years Of Arctic History
  • Why Doesn’t Moonrise Shift By The Same Amount Each Night?
  • Moa De-Extinction, Fashionable Chimps, And Robot Surgery – No Human Required
  • “Human”: Powerful New Images Mark The Most Scientifically Accurate “Hyper-Real 3D Models Of Human Species Ever”
  • Did We Accidentally Leave Life On The Moon In 2019 – And Could We Revive It?
  • 1.8 Million Years Ago, Two Extinct Humans Had One Of The Gnarliest Deaths In History
  • “Powerful Image” Of One Of The World’s Rarest Tigers Exposes The Real Danger In Taman Negara
  • Evolution, Domestication, And A Lot Of Very Good Boys: How Wolves Became Dogs
  • Why Do Orcas Have White Spots Near Their Eyes?
  • Tomb Of First King Of Ancient Maya City Discovered In Belize
  • The Real Reason The Tip Of Your Tape Measure Wiggles Like That
  • The “Haunting” Last Message From NASA’s Opportunity Rover, Sent From Inside A Planet-Wide Storm
  • Adorable Video Proves Not All Gorillas Hate The Rain. It Might Even Win One A Mate
  • 5,000-Year-Old Rock Art May Show One Of Ancient Egypt’s First Rulers
  • Alzheimer’s-Linked Protein Levels “20 Times Higher” In Newborn Babies – What Does This Mean?
  • Americans Were Asked If They Thought Civil War Was Coming. The Results Were Unexpected
  • Voyager 1 & 2 Could Be Detected From Almost A Light-Year Away With Our Current Technology
  • Dams Have Nudged Earth’s Poles By Over 1 Meter In The Past 200 Years
  • This Sugar Could Be A Cure For Male Pattern Baldness – And It’s Been In Our Bodies All Along
  • “Cosmic Immigrants”: Daytime Star Seen In 1604 May Be An “Alien Type Ia Supernova”
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version